After receiving his S.B. degree from MIT and a combined MD and PhD from Harvard Medical School, Dr. Stanger completed a residency in Internal Medicine at the University of California, San Francisco, a clinical fellowship in Gastroenterology at Massachusetts General Hospital, and a research fellowship in Molecular Biology at Harvard. In 2006, he joined the Penn faculty as a member of the Gastroenterology Division and the Abramson Family Cancer Research Institute. Dr. Stanger’s laboratory investigates multiple aspects of pancreatic cancer biology, including metastasis, tumor immunology, metabolism, and therapy resistance. His research integrates mouse models and human data to identify new vulnerabilities that can be assessed clinically. He is currently the Hanna Wise Professor in Cancer Research at the University of Pennsylvania, where he serves as Director of the Pancreatic Cancer Research Center (PCRC).